180 Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Buy
9,225
+2,757
+43% +$150K 0.04% 327
2026
Q1
$406K Buy
6,468
+223
+4% +$17.8K 0.05% 308
2025
Q4
$595K Buy
6,245
+681
+12% +$66.8K 0.07% 248
2025
Q3
$543K Sell
5,564
-467
-8% -$48.4K 0.07% 249
2025
Q2
$648K Sell
6,031
-216
-3% -$21.9K 0.09% 210
2025
Q1
$630K Buy
6,247
+118
+2% +$11.9K 0.1% 195
2024
Q4
$547K Buy
6,129
+24
+0.4% +$2.11K 0.09% 211
2024
Q3
$512K Sell
6,105
-87
-1% -$6.86K 0.08% 220
2024
Q2
$476K Buy
6,192
+571
+10% +$41.8K 0.08% 224
2024
Q1
$385K Buy
5,621
+1,504
+37% +$96.7K 0.07% 251
2023
Q4
$238K Buy
4,117
+49
+1% +$2.62K 0.05% 318
2023
Q3
$215K Sell
4,068
-40
-1% -$2.1K 0.05% 319
2023
Q2
$220K Hold
4,108
0.05% 313
2023
Q1
$206K Buy
+4,108
New +$194K 0.05% 331
2021
Q1
Sell
-8,124
Closed -$295K 346
2020
Q4
$295K Buy
+8,124
New +$293K 0.09% 225
2020
Q3
Sell
-5,524
Closed -$208K 266
2020
Q2
$208K Buy
+5,524
New +$199K 0.08% 239

Other funds holding BSX

180 Wealth Advisors's BSX Position: Q2 2026 in Review

180 Wealth Advisors increased its Boston Scientific (BSX) stake by 43% in Q2 2026, buying an estimated $150K and bringing the position to 9,225 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #327.

180 Wealth Advisors first reported a position in BSX in Q2 2020 and has held it in 16 quarters since. The position peaked at $648K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • 180 Wealth Advisors held 9,225 shares of Boston Scientific worth $394K as of Q2 2026.
  • 180 Wealth Advisors bought 2,757 Boston Scientific shares in Q2 2026, an estimated $150K.
  • Boston Scientific made up 0.04% of 180 Wealth Advisors's portfolio in Q2 2026, its #327 holding.
  • 180 Wealth Advisors first reported a position in Boston Scientific in Q2 2020 and has held it in 16 quarters since.
  • 180 Wealth Advisors's Boston Scientific position peaked at $648K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.